Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy
More recently, the SELECT trial (2023) extended these findings to adults with obesity but without diabetes, demonstrating a 20% cardiovascular event reduction and significant improvements in LDL cholesterol, non-HDL cholesterol, and triglyceride levels
However, its up to the patient to cover any medication cost their insurance provider doesnt
Some people are born with lymphatic system problems (primary lymphedema), but most cases develop after cancer treatment, surgery, radiation, infection, or injury (secondary lymphedema)
Step 3: Personalized Program Design If you are eligible, we will design a program tailored to you